Activation of NF-κB in Placentas of Women with Preeclampsia

REFERENCES

• Baldwin AS. The NF-kB and IkB proteins: New discoveries and insights. Annu Rev Immunol 1996; 14:649–681.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Karin M. Nuclear factor-kB: A pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997; 336:1066–1071.
   PubMed Web of Science ®Google Scholar
• Winyard PG, Blake DR. Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 1997; 38:403–421.
   PubMedGoogle Scholar
• Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10:2247–2258.
   PubMed Web of Science ®Google Scholar
• Los M, Droge W, Stricker K, Baeuerle PA, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 1995; 25:159–165.
   PubMed Web of Science ®Google Scholar
• Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993; 92:471–478.
   PubMed Web of Science ®Google Scholar
• Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992; 17:221–237.
   PubMed Web of Science ®Google Scholar
• Walsh SW. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152:335–340.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995; 80:1888–1893.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y, Jesse R. Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertens Pregnancy 1996; 15:101–111.
   Web of Science ®Google Scholar
• Wang Y, Walsh SW. TNFa concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157–169.
   PubMed Web of Science ®Google Scholar
• Shah T, Walsh SW. Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am J Obstet Gynecol 2007; 196(1):48.e1–48.e8.
   Web of Science ®Google Scholar
• Kniss D, Xie Y, Li Y, ED27 trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype. Placenta 2002; 23:32–43.
   PubMed Web of Science ®Google Scholar
• Fowler AA, III, Fisher BJ, Sweeney LB, . Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-B binding to DNA: Effects on endothelial function. Biochem Cell Biol 1999; 77:201–208.
   PubMedGoogle Scholar
• Dechend R, Viedt C, Muller DN, AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003; 107:1632–1639.
   PubMed Web of Science ®Google Scholar
• Cooke CL, Brockelsby JC, Baker PN, Davidge ST. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy 2003; 22:173–184.
   PubMed Web of Science ®Google Scholar
• Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, Deloia JA. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 2006; 56:135–144.
   PubMed Web of Science ®Google Scholar
• Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 2001; 15:279–281.
   PubMed Web of Science ®Google Scholar
• Lindstrom TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction 2005; 130:569–581.
   PubMed Web of Science ®Google Scholar
• Johnson RD, Sadovsky Y, Graham C, . The expression and activity of prostaglandin H synthase-2 is enhanced in trophoblast from women with preeclampsia. J Clin Endocrinol Metab 1997; 82:3059–3062.
   PubMedGoogle Scholar
• Vaughan JE, Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Pregnancy 2002; 21:205–223.
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996; 3:179–184.
   PubMedGoogle Scholar
• Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregnancy 1994; 13:1–32.
   Web of Science ®Google Scholar
• Leik C, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 2004; 44:72–77.
   PubMed Web of Science ®Google Scholar
• Gratacos E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996; 75:896–901.
   PubMed Web of Science ®Google Scholar
• Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994; 13:103–109.
   Web of Science ®Google Scholar
• Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 1995; 102:530–537.
   PubMedGoogle Scholar
• Chung R, Davis H, Ma Y, Naivikul O, Williams C, Wilson K. Diet-related toxemia in pregnancy. I. Fat, fatty acids, and cholesterol. Am J Clin Nutr 1979; 32:1902–1911.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-a is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752–1759.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40:102–111.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88:420–427.
   PubMed Web of Science ®Google Scholar
• Laskowska M, Laskowska K, Leszczynska-Gorzelak B, Oleszczuk J. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. J Matern Fetal Neonatal Med 2007; 20:527–532.
   PubMed Web of Science ®Google Scholar
• Jendryczko A, Drozdz M. Increased placental phospholipase A2 activities in pre-eclampsia. Zbl Gynakol 1990; 112:889–891.
   PubMedGoogle Scholar
• Lim K-H, Rice GE, de Groot CJM, Taylor RN. Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 1995; 172:998–1002.
   PubMedGoogle Scholar
• Krauss T, Kuhn W, Lakoma C, Augustin H. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997; 177:443–449.
   PubMed Web of Science ®Google Scholar
• Clausen T, Djurovic S, Brosstad F, Berg K, Henricksen T. Altered circulating levels of adhesion molecules at 18 weeks’ gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000; 182:321–325.
   PubMed Web of Science ®Google Scholar
• Phocas I, Rizos D, Papoulias J, Xyni K, Sarandakou A, Salamalekis E. A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia. J Perinatol 2000; 20:114–119.
   PubMedGoogle Scholar